Laura S Fernandes

Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?. Lessons from the ESPRIT study.

J. Hochman, J. Tcheng, N. Kleiman, 2002, Journal of the American College of Cardiology.

Platelet–monocyte complex formation: effect of blocking PSGL-1 alone, and in combination with αIIbβ3 and αMβ2, in coronary stenting

L. McIntire, C. Smith, C. Ballantyne, 2003 .

Platelet-monocyte complex formation: effect of blocking PSGL-1 alone, and in combination with alphaIIbbeta3 and alphaMbeta2, in coronary stenting.

L. McIntire, C. Ballantyne, N. Kleiman, 2003, Thrombosis research.

Pharmacodynamic profile of the direct thrombin antagonist bivalirudin given in combination with the glycoprotein IIb/IIIa antagonist eptifibatide.

S. Solomon, N. Kleiman, U. Arora, 2002, American heart journal.